- All sections
- C - Chemistrymetallurgy
- C07H - Sugarsderivatives thereofnucleosidesnucleotidesnucleic acids
- C07H 11/04 - PhosphatesPhosphitesPolyphosphates
Patent holdings for IPC class C07H 11/04
Total number of patents in this class: 135
10-year publication summary
|
9
|
14
|
9
|
10
|
6
|
5
|
11
|
4
|
9
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gilead Sciences, Inc. | 2226 |
8 |
| The Governing Council of The University of Toronto, | 1552 |
8 |
| Metro International Biotech, LLC | 41 |
8 |
| National Research Council of Canada | 1548 |
6 |
| University of Maryland, Baltimore | 1067 |
4 |
| Centre National de La Recherche Scientifique | 11026 |
3 |
| The Brigham and Women's Hospital, Inc. | 2286 |
3 |
| Glycomine, Inc. | 16 |
3 |
| Glytech, Inc. | 62 |
3 |
| Immune Design Corp. | 36 |
3 |
| Isis Innovation Limited | 447 |
3 |
| Rijksuniversiteit Groningen | 317 |
3 |
| BASF SE | 21308 |
2 |
| The United States of America as represented by the Secretary of the Navy | 2860 |
2 |
| President and Fellows of Harvard College | 6092 |
2 |
| Duke University | 3182 |
2 |
| Eth Zurich | 1323 |
2 |
| GlycoVaxyn AG | 15 |
2 |
| Horizon Technology Finance Corporation | 22 |
2 |
| University of Georgia Research Foundation, Inc. | 1073 |
2 |
| Other owners | 64 |